Ranking the wreckage: $NKE > $LULU > $CMG
$NKE is the worst setup. Inventory bloat, DTC margin compression, China weakness isn't bottoming, and the brand's lost premium positioning in North America. They're discounting into a demand problem. The turnaround story needs 18+ months and multiple quarters of proof. Avoid until you see actual sell-through improvement and margin stabilization.
$LULU second-worst. Growth deceleration is real, men's category isn't offsetting women's slowdown, and international expansion is expensive with long payback periods. Valuation still pricing in growth they're not delivering. That said, brand strength holds better than $NKE, and loyalty metrics aren't falling off a cliff. If it breaks below $340 convincingly, maybe a small position for a 2025 recovery trade, but it's not a buy here.
$CMG least bad. Yeah, the valuation's stupid and traffic's moderating, but unit economics still work, pricing power's intact, and they're not sitting on dead inventory or fighting a brand crisis. Comp slowdown was expected after the post-COVID rip. I wouldn't chase it at 50x, but if it pulls back to $50-52 on macro fear, that's actually interesting for a swing.
Bottom line: $NKE's a structural mess, $LULU's a stretched growth story, $CMG's just expensive. If forced to short one, short $NKE. If forced to own one on a pullback, $CMG's the only one I'd consider.
$NKE is the worst setup. Inventory bloat, DTC margin compression, China weakness isn't bottoming, and the brand's lost premium positioning in North America. They're discounting into a demand problem. The turnaround story needs 18+ months and multiple quarters of proof. Avoid until you see actual sell-through improvement and margin stabilization.
$LULU second-worst. Growth deceleration is real, men's category isn't offsetting women's slowdown, and international expansion is expensive with long payback periods. Valuation still pricing in growth they're not delivering. That said, brand strength holds better than $NKE, and loyalty metrics aren't falling off a cliff. If it breaks below $340 convincingly, maybe a small position for a 2025 recovery trade, but it's not a buy here.
$CMG least bad. Yeah, the valuation's stupid and traffic's moderating, but unit economics still work, pricing power's intact, and they're not sitting on dead inventory or fighting a brand crisis. Comp slowdown was expected after the post-COVID rip. I wouldn't chase it at 50x, but if it pulls back to $50-52 on macro fear, that's actually interesting for a swing.
Bottom line: $NKE's a structural mess, $LULU's a stretched growth story, $CMG's just expensive. If forced to short one, short $NKE. If forced to own one on a pullback, $CMG's the only one I'd consider.